BTMD Insider Trading
Insider Ownership Percentage: 24.00%
Insider Buying (Last 12 Months): $3,141,551.44
Insider Selling (Last 12 Months): $86,116.32
biote Share Price & Price History
Current Price: $3.51
Price Change: ▲ Price Increase of +0.1 (2.93%)
As of 04/22/2025 01:00 PM ET
biote Insider Trading History
biote Institutional Trading History
Data available starting January 2016
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Read More on biote
Volume
14,939 shs
Average Volume
186,120 shs
Market Capitalization
$192.03 million
P/E Ratio
13.44
Dividend Yield
N/A
Beta
1.17
Who are the company insiders with the largest holdings of biote?
Who are the major institutional investors of biote?
Which institutional investors are selling biote stock?
During the last quarter, BTMD stock was sold by these institutional investors:
- Sanders Morris Harris LLC